Statements (20)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
Hirofumi Imai
|
| gptkbp:country |
gptkb:Japan
|
| gptkbp:focusArea |
women's health
diagnostics acute care |
| gptkbp:founded |
1965
|
| gptkbp:headquarters_location |
gptkb:Tokyo
|
| https://www.w3.org/2000/01/rdf-schema#label |
Fuji Pharma Co., Ltd.
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:numberOfEmployees |
over 1,000
|
| gptkbp:products |
generic drugs
prescription drugs injectable drugs hormonal drugs |
| gptkbp:stockExchange |
gptkb:Tokyo_Stock_Exchange
|
| gptkbp:stockSymbol |
4554
|
| gptkbp:website |
https://www.fujipharma.jp/
|
| gptkbp:bfsParent |
gptkb:Kyowa_Pharmaceutical_Industry_Co.
|
| gptkbp:bfsLayer |
8
|